Announcements
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
- Broker Announcement
More ▼
Key statistics
On Friday, Angle PLC (ANPCY:QXE) closed at 2.90, -27.50% below its 52-week high of 4.00, set on Jan 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.00 |
---|---|
High | 3.22 |
Low | 2.56 |
Bid | -- |
Offer | -- |
Previous close | 2.90 |
Average volume | 6.99k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 10 2024 16:31 BST.
More ▼